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Introduction. Platelet-rich-plasma (PRP) of peripheral blood contains valuable natural growth 
factors, such as: PDGF, TGF, PDAF, VEGF, EGF and presents a suitable alternative to xenogeneic 
supplements for ex vivo propagation of mesenchymal stem cells (MSCs). Currently, for 
differentiation of MSCs from pluripotent stem cells (PSC) a fetal bovine serum (FBS) as a cell 
culture supplement is commonly used with FGF, PDGF, EGF. Replacement of the FBS with PRP to 
support the cell growth may reduce risks of transfer xenogeneic infection. Hence, differentiation 
using PRP presents a promising alternative for generation of pluripotent-derived MSCs (PD-
MSCs). In this regard, the aim was to study the effect of PRP lysate as the natural supplement on 
differentiation of PSCs into MSCs. 
Methods. Karyotypically normal and homogeneous PSCs were maintained in xeno-free and 
feeder-independent conditions. Pluripotent characteristics of PSCs were assessed with alkaline 
phosphatase staining, immunofluorescence and RT-PCR analysis. Isolation of PRP from healthy 
donor was performed using PRP kit (Neogenesis, Korea). PRP lysate preparation was conducted 
using freeze-thawing cycles and ultracentrifugation. For MSCs differentiation, PSCs were cultured 
in E8 xeno-free medium (Gibco, USA) supplemented with PRP lysate for period of 11 days. For the 
control, the same cells were cultured in complete E8 xeno-free medium. After differentiation, the 
obtained PD-MSCs were characterized using morphological and immunofluorescence analysis. 
Results. Our results demonstrated that PRP lysate is able to induce the differentiation of PSCs to 
MSCs. The first morphological changes of PSCs were appeared on the 8-th day. In these cells the 
lack of expression of the transcription factor Oct-4 was identified on the 11-th day. The data of 
immunofluorescence analysis showed the expression of MSC markers, including membrane 
glycoprotein - CD105, which was detected on the 11-th day of differentiation. Moreover, it was 
revealed that generated PD-MSCs had spindle-shape cell morphology, which is characteristic of the 
normal MSCs, and high proliferation potential. 
Conclusion. Our preliminary data shows that the use of PRP lysate as the natural supplement of 
important growth factors have significant potential for reproducible, cost-effective generation of 
biocompatible and immunomodulatory PD-MSCs for clinical cell therapy. 
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